The Fund seeks to track the investment results of the ICE Biotechnology Index, which measures the performance of US-listed securities of companies that are classified within the Biotechnology Sub-Industry Group. The Fund generally invests at least 90% of its assets in securities of the Underlying Index.
| Classification | Inception Date | Primary Exchange |
|---|---|---|
| Health/Biotech Funds | 02/05/2001 | Nasdaq |
Investment Information
| Market Cap | 8.62B |
| Net Assets | 9.98B |
| NAV | 128.51 |
| Shares Outstanding | 66.95M |
| Avg Daily Vol | 2.49M |
| Dividend Yield | 0.25% |
| Dividend | 0.04 |
| Ex Dividend Date | 12/13/21 |
Detailed Information
| Mgmt Co | BlackRock |
| Turnover | 34.00% |
| Beta | 0.68 |
| P/E | 23.88 |
| P/B | 9.27 |
| Expense Ratio | 0.45% |
To receive a prospectus
BlackRock4400 Computer Drive
Westborough, MA 01581
800-474-2737
Performance
| IBB | S&P 500 TR IX | |
|---|---|---|
| 1 week | -7.52 | -5.67 |
| 4 weeks | -16.97 | -6.86 |
| 3 months | -18.83 | -2.90 |
| 1 year | -21.18 | 15.76 |
| 3 years | 5.36 | 20.10 |
| 5 years | 7.36 | 16.23 |
| 10 years | 13.27 | 15.09 |
